J L Gerberding

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Clinical practice. Occupational exposure to HIV in health care settings
    Julie Louise Gerberding
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 348:826-33. 2003
  2. ncbi Health-care quality promotion through infection prevention: beyond 2000
    J L Gerberding
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:363-6. 2001
  3. ncbi Hospital-onset infections: a patient safety issue
    Julie Louise Gerberding
    Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Ann Intern Med 137:665-70. 2002
  4. ncbi Protecting health--the new research imperative
    Julie L Gerberding
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 294:1403-6. 2005
  5. ncbi Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States
    J A Jernigan
    NCID, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:933-44. 2001
  6. ncbi Management of occupational and nonoccupational postexposure HIV prophylaxis
    Mitchell H Katz
    San Francisco Department of Public Health, 101 Grove Street, San Francisco, CA 94102, USA
    Curr HIV/AIDS Rep 1:159-65. 2004
  7. ncbi Anthrax bioterrorism: lessons learned and future directions
    James M Hughes
    National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Emerg Infect Dis 8:1013-4. 2002
  8. ncbi Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital
    Lisa G Winston
    University of California, San Francisco/San Francisco General Hospital, 94110, USA
    Am J Infect Control 30:400-6. 2002
  9. ncbi Medicine. The need for a global HIV vaccine enterprise
    Richard D Klausner
    Bill and Melinda Gates Foundation, Seattle, WA 98102, USA
    Science 300:2036-9. 2003
  10. ncbi Julie Louise Gerberding--director of the Centers for Disease Control and Prevention. Interview by Pam Das
    Julie Louise Gerberding
    Lancet Infect Dis 4:178-81. 2004

Collaborators

Detail Information

Publications10

  1. ncbi Clinical practice. Occupational exposure to HIV in health care settings
    Julie Louise Gerberding
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 348:826-33. 2003
  2. ncbi Health-care quality promotion through infection prevention: beyond 2000
    J L Gerberding
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:363-6. 2001
    ..Among the change drivers influencing themes of future conferences may be a societal mandate for health promotion and health-care access for all...
  3. ncbi Hospital-onset infections: a patient safety issue
    Julie Louise Gerberding
    Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Ann Intern Med 137:665-70. 2002
    ....
  4. ncbi Protecting health--the new research imperative
    Julie L Gerberding
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 294:1403-6. 2005
  5. ncbi Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States
    J A Jernigan
    NCID, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:933-44. 2001
    ..With multidrug antibiotic regimens and supportive care, survival of patients (60%) was markedly higher (<15%) than previously reported...
  6. ncbi Management of occupational and nonoccupational postexposure HIV prophylaxis
    Mitchell H Katz
    San Francisco Department of Public Health, 101 Grove Street, San Francisco, CA 94102, USA
    Curr HIV/AIDS Rep 1:159-65. 2004
    ....
  7. ncbi Anthrax bioterrorism: lessons learned and future directions
    James M Hughes
    National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Emerg Infect Dis 8:1013-4. 2002
  8. ncbi Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital
    Lisa G Winston
    University of California, San Francisco/San Francisco General Hospital, 94110, USA
    Am J Infect Control 30:400-6. 2002
    ..VREF persisted in individual patients up to 46 months. CONCLUSIONS: The number of VREF infections in this facility has been low, despite appreciable colonization, for an extended period during which selective isolation was used...
  9. ncbi Medicine. The need for a global HIV vaccine enterprise
    Richard D Klausner
    Bill and Melinda Gates Foundation, Seattle, WA 98102, USA
    Science 300:2036-9. 2003
    ....
  10. ncbi Julie Louise Gerberding--director of the Centers for Disease Control and Prevention. Interview by Pam Das
    Julie Louise Gerberding
    Lancet Infect Dis 4:178-81. 2004